In cervical cancer, PBX3 overexpression promotes proliferation through the AKT pathway, and high levels of expression in primary tumors are associated with a poor prognosis [57], and, as with the other cancers described above, PBX3 expression is suppressed by an miR, miR-526b, preventing cells from undergoing EMT [35]. The gene discussed is PBX3; the disease is cancer.